Christopher J McDermott
Overview
Explore the profile of Christopher J McDermott including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
134
Citations
2734
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boddy S, Simpson R, Walters S, Walsh T, McDermott C
Amyotroph Lateral Scler Frontotemporal Degener
. 2025 Mar;
:1-9.
PMID: 40065553
Oral secretion problems are common yet poorly managed in people living with MND (plwMND). A validated patient-reported outcome for measuring saliva symptoms in this patient group would facilitate better monitoring...
2.
Murray D, Rooney J, Meldrum D, Al-Chalabi A, Bunte T, Chiwera T, et al.
Amyotroph Lateral Scler Frontotemporal Degener
. 2025 Mar;
:1-11.
PMID: 40047382
: Progressing respiratory weakness throughout the course of amyotrophic lateral sclerosis (ALS) is clinically associated with distressing symptoms, including dyspnea, orthopnea, and difficulty clearing secretions. Fatigue, poor sleep, and reduced...
3.
Howard J, Bekker H, McDermott C, McNeill A
Amyotroph Lateral Scler Frontotemporal Degener
. 2025 Feb;
:1-8.
PMID: 40013906
Whole Genome Sequencing (WGS) for amyotrophic lateral sclerosis (ALS) (also known as motor neuron disease, MND) raises multiple considerations and has a range of implications for individuals and their family....
4.
Boddy S, Simpson R, Walters S, Bamford H, Walsh T, McDermott C
Amyotroph Lateral Scler Frontotemporal Degener
. 2025 Feb;
:1-10.
PMID: 39898446
: The Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R) is a commonly used outcome measure in clinical trials for motor neuron disease (MND) therapies. As such, understanding how differences in...
5.
Young C, Chaouch A, McDermott C, Al-Chalabi A, Chhetri S, Bidder C, et al.
Amyotroph Lateral Scler Frontotemporal Degener
. 2025 Jan;
:1-11.
PMID: 39749679
: Stigma in amyotrophic lateral sclerosis/motor neurone disease (ALS/MND) may be felt or enacted; felt stigma covers feeling devalued by the illness, whereas enacted stigma refers to being treated differently...
6.
Bakshi B, Yerraguntla S, Armon C, Barkhaus P, Bertorini T, Bowser R, et al.
Amyotroph Lateral Scler Frontotemporal Degener
. 2024 Dec;
:1-4.
PMID: 39709547
ALSUntangled reviews alternate and off-label treatments prompted by patient interest. Here, we review psilocybin, a chemical derived from mushrooms and belonging in the category of drugs known as psychedelics. Psilocybin...
7.
Qiang Z, Barnett L, Bingham G, Han O, Walsh A, Conwill M, et al.
J Neurol
. 2024 Dec;
272(1):35.
PMID: 39666128
Myopathies are heterogenous and can provide a diagnostic puzzle. Many patients investigated for myopathy will go on to other diagnoses. An overall understanding of how patients are investigated for suspected...
8.
Allen S, Howard J, McDermott C, Boardman F, McNeill A
Amyotroph Lateral Scler Frontotemporal Degener
. 2024 Oct;
:1-12.
PMID: 39422440
Objectives: To examine the knowledge, confidence and practice of motor neuron disease (MND) clinicians toward discussing reproductive options with people who carry a causal variant in an MND gene (both...
9.
Li X, Wicks P, Brown A, Shivaprasad A, Greene M, Crayle J, et al.
Amyotroph Lateral Scler Frontotemporal Degener
. 2024 Oct;
26(1-2):181-185.
PMID: 39385461
The Wahls diet is a modified Paleolithic diet that emphasizes dark green leafy vegetables, colorful fruits, high-quality animal proteins, and omega-3 polyunsaturated fatty acids, while limiting grains, legumes, dairy products,...
10.
Roscoe S, Allen S, McDermott C, Stavroulakis T
Nutr Rev
. 2024 Oct;
PMID: 39375842
Objective: To map the international methods used to measure energy expenditure of adults living with motor neuron disease (MND) and to highlight discrepancies when indicating hypermetabolism in the MND literature....